Literature DB >> 8990112

p53 and treatment of bladder cancer.

R J Cote, D Esrig, S Groshen, P A Jones, D G Skinner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8990112     DOI： 10.1038/385123b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  39 in total

1.  Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Toshiro Wakatsuki; Masahide Ikeguchi; Ken Shirabe; Masaru Morita; Yoshihiro Kakeji; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

2.  Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.

Authors:  Douglas A Mata; Susan Groshen; Friedrich-Carl Von Rundstedt; Donald G Skinner; Walter M Stadler; Richard J Cote; John P Stein; Seth P Lerner
Journal:  J Surg Oncol       Date:  2015-04-14       Impact factor: 3.454

Review 3.  Neoadjuvant chemotherapy for bladder cancer.

Authors:  Peter C Black; Gordon A Brown; H Barton Grossman; Colin P Dinney
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 4.  Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.

Authors:  Christopher Y Thomas; Dan Theodorescu
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

5.  Invasive bladder cancer: ignoring the data.

Authors:  Derek Raghavan
Journal:  Oncologist       Date:  2013

6.  Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.

Authors:  Walter M Stadler; Seth P Lerner; Susan Groshen; John P Stein; Shan-Rong Shi; Derek Raghavan; David Esrig; Gary Steinberg; David Wood; Laurence Klotz; Craig Hall; Donald G Skinner; Richard J Cote
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

7.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

Review 8.  Use of nomograms as predictive tools in bladder cancer.

Authors:  Ahmad Shabsigh; Bernard H Bochner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 9.  Emerging personalized approaches for the management of advanced urothelial carcinoma.

Authors:  Che-Kai Tsao; Benjamin A Gartrell; William K Oh; Matthew D Galsky
Journal:  Expert Rev Anticancer Ther       Date:  2012-12       Impact factor: 4.512

Review 10.  Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.

Authors:  Robert T Jones; Kenneth M Felsenstein; Dan Theodorescu
Journal:  Urol Clin North Am       Date:  2015-10-31       Impact factor: 2.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.